Tender offer for Science 37 by eMed commences

eMed’s wholly-owned subsidiary Marlin Merger Sub has commenced a cash tender offer to purchase all the outstanding shares of common stock, par value $0.0001 per share, of Science 37 for a price of $5.75 per share. A successful consummation of the tender offer will be followed by a merger to acquire any untendered shares of Science 37 for the same price payable in the tender offer. The offer will expire at 12:00 midnight, NYC time, at the end of the day of March 11, unless extended. The offer is subject to customary closing conditions, including the tender of at least a majority in voting power of the shares of Science 37 common stock then issued and outstanding and is not subject to a financing condition.